Which has preferable valuation & earnings, QGEN or ILMN?

Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Qiagen $2.10B 3.98 $424.88M $1.91 21.24 Illumina $4.39B 6.57 $850M $5.50 34.70

Is QGEN or ILMN more profitable?

Illumina has a net margin of 19.42% compared to Qiagen's net margin of 19.16%. Illumina's return on equity of 31.01% beat Qiagen's return on equity. Company Net Margins Return on Equity Return on Assets Qiagen 19.16% 14.40% 8.40% Illumina 19.42% 31.01% 12.22%

Does the media prefer QGEN or ILMN?

In the previous week, Illumina had 19 more articles in the media than Qiagen. MarketBeat recorded 23 mentions for Illumina and 4 mentions for Qiagen. Illumina's average media sentiment score of 1.10 beat Qiagen's score of 0.99 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 17 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor TMO or ILMN?

In the previous week, Thermo Fisher Scientific had 18 more articles in the media than Illumina. MarketBeat recorded 41 mentions for Thermo Fisher Scientific and 23 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.31 beat Illumina's score of 1.10 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 33 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Illumina 17 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor A or ILMN?

In the previous week, Illumina had 6 more articles in the media than Agilent Technologies. MarketBeat recorded 23 mentions for Illumina and 17 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.27 beat Illumina's score of 1.10 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 15 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 17 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Which has better earnings and valuation, ILMN or WAT?

Illumina has higher revenue and earnings than Waters. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Illumina $4.39B 6.57 $850M $5.50 34.70 Waters $3.17B 11.51 $642.63M $7.87 47.13

Is ILMN or WAT more profitable?

Illumina has a net margin of 19.42% compared to Waters' net margin of 11.91%. Illumina's return on equity of 31.01% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Illumina 19.42% 31.01% 12.22% Waters 11.91% 15.60% 8.90%

Does the media refer more to ILMN or WAT?

In the previous week, Waters had 4 more articles in the media than Illumina. MarketBeat recorded 27 mentions for Waters and 23 mentions for Illumina. Waters' average media sentiment score of 1.18 beat Illumina's score of 1.10 indicating that Waters is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 17 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Waters 19 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to ILMN or MTD?

In the previous week, Illumina had 11 more articles in the media than Mettler-Toledo International. MarketBeat recorded 23 mentions for Illumina and 12 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.21 beat Illumina's score of 1.10 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 17 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Mettler-Toledo International 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Illumina (ILMN) Competitors

$190.87 -1.66 (-0.86%)

Closing price 04:00 PM Eastern

Extended Trading

$190.92 +0.06 (+0.03%)

As of 04:42 PM Eastern

Compare

ILMN vs. QGEN, TMO, A, WAT, and MTD

Should you buy Illumina stock or one of its competitors? MarketBeat compares Illumina with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Illumina include Qiagen (QGEN), Thermo Fisher Scientific (TMO), Agilent Technologies (A), Waters (WAT), and Mettler-Toledo International (MTD). These companies are all part of the "medical" sector.

How does Illumina compare to Qiagen?

Qiagen (NYSE:QGEN) and Illumina (NASDAQ:ILMN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$2.10B	3.98	$424.88M	$1.91	21.24
Illumina	$4.39B	6.57	$850M	$5.50	34.70

Qiagen presently has a consensus target price of $43.34, suggesting a potential upside of 6.82%. Illumina has a consensus target price of $156.88, suggesting a potential downside of 17.81%. Given Qiagen's higher possible upside, analysts plainly believe Qiagen is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.36
Illumina	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.37

Illumina has a net margin of 19.42% compared to Qiagen's net margin of 19.16%. Illumina's return on equity of 31.01% beat Qiagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	19.16%	14.40%	8.40%
Illumina	19.42%	31.01%	12.22%

70.0% of Qiagen shares are owned by institutional investors. Comparatively, 89.4% of Illumina shares are owned by institutional investors. 9.0% of Qiagen shares are owned by company insiders. Comparatively, 2.9% of Illumina shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Illumina had 19 more articles in the media than Qiagen. MarketBeat recorded 23 mentions for Illumina and 4 mentions for Qiagen. Illumina's average media sentiment score of 1.10 beat Qiagen's score of 0.99 indicating that Illumina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	17 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Qiagen has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, Illumina has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

Summary

Illumina beats Qiagen on 14 of the 17 factors compared between the two stocks.

How does Illumina compare to Thermo Fisher Scientific?

Thermo Fisher Scientific (NYSE:TMO) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 89.4% of Illumina shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by insiders. Comparatively, 2.9% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Illumina has a net margin of 19.42% compared to Thermo Fisher Scientific's net margin of 15.15%. Illumina's return on equity of 31.01% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.15%	16.86%	8.15%
Illumina	19.42%	31.01%	12.22%

In the previous week, Thermo Fisher Scientific had 18 more articles in the media than Illumina. MarketBeat recorded 41 mentions for Thermo Fisher Scientific and 23 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.31 beat Illumina's score of 1.10 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	33 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Illumina	17 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Thermo Fisher Scientific has higher revenue and earnings than Illumina. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$45.20B	4.33	$6.70B	$18.19	28.93
Illumina	$4.39B	6.57	$850M	$5.50	34.70

Thermo Fisher Scientific has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Illumina has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

Thermo Fisher Scientific currently has a consensus price target of $602.14, indicating a potential upside of 14.43%. Illumina has a consensus price target of $156.88, indicating a potential downside of 17.81%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, equities analysts clearly believe Thermo Fisher Scientific is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.84
Illumina	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.37

Summary

Thermo Fisher Scientific beats Illumina on 9 of the 17 factors compared between the two stocks.

How does Illumina compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

Agilent Technologies has higher revenue and earnings than Illumina. Agilent Technologies is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$7.23B	5.21	$1.30B	$4.98	26.81
Illumina	$4.39B	6.57	$850M	$5.50	34.70

Agilent Technologies has a net margin of 19.55% compared to Illumina's net margin of 19.42%. Illumina's return on equity of 31.01% beat Agilent Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Illumina	19.42%	31.01%	12.22%

In the previous week, Illumina had 6 more articles in the media than Agilent Technologies. MarketBeat recorded 23 mentions for Illumina and 17 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.27 beat Illumina's score of 1.10 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	15 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	17 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Agilent Technologies presently has a consensus target price of $159.35, indicating a potential upside of 19.38%. Illumina has a consensus target price of $156.88, indicating a potential downside of 17.81%. Given Agilent Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe Agilent Technologies is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.89
Illumina	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.37

Agilent Technologies has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, Illumina has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

87.4% of Agilent Technologies shares are owned by institutional investors. Comparatively, 89.4% of Illumina shares are owned by institutional investors. 0.2% of Agilent Technologies shares are owned by company insiders. Comparatively, 2.9% of Illumina shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Agilent Technologies beats Illumina on 9 of the 17 factors compared between the two stocks.

How does Illumina compare to Waters?

Illumina (NASDAQ:ILMN) and Waters (NYSE:WAT) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Illumina has a net margin of 19.42% compared to Waters' net margin of 11.91%. Illumina's return on equity of 31.01% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	19.42%	31.01%	12.22%
Waters	11.91%	15.60%	8.90%

In the previous week, Waters had 4 more articles in the media than Illumina. MarketBeat recorded 27 mentions for Waters and 23 mentions for Illumina. Waters' average media sentiment score of 1.18 beat Illumina's score of 1.10 indicating that Waters is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	17 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Waters	19 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

89.4% of Illumina shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 2.9% of Illumina shares are held by company insiders. Comparatively, 0.3% of Waters shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Illumina has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market. Comparatively, Waters has a beta of 1.2, indicating that its stock price is 20% more volatile than the broader market.

Illumina presently has a consensus price target of $156.88, indicating a potential downside of 17.81%. Waters has a consensus price target of $401.60, indicating a potential upside of 8.27%. Given Waters' stronger consensus rating and higher possible upside, analysts plainly believe Waters is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.37
Waters	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.71

Illumina has higher revenue and earnings than Waters. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.39B	6.57	$850M	$5.50	34.70
Waters	$3.17B	11.51	$642.63M	$7.87	47.13

Summary

Waters beats Illumina on 9 of the 16 factors compared between the two stocks.

How does Illumina compare to Mettler-Toledo International?

Illumina (NASDAQ:ILMN) and Mettler-Toledo International (NYSE:MTD) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

Mettler-Toledo International has a net margin of 21.40% compared to Illumina's net margin of 19.42%. Illumina's return on equity of 31.01% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	19.42%	31.01%	12.22%
Mettler-Toledo International	21.40%	-622.80%	24.97%

In the previous week, Illumina had 11 more articles in the media than Mettler-Toledo International. MarketBeat recorded 23 mentions for Illumina and 12 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.21 beat Illumina's score of 1.10 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	17 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Illumina currently has a consensus target price of $156.88, indicating a potential downside of 17.81%. Mettler-Toledo International has a consensus target price of $1,408.55, indicating a potential upside of 9.53%. Given Mettler-Toledo International's stronger consensus rating and higher probable upside, analysts plainly believe Mettler-Toledo International is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.37
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Illumina has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market.

Mettler-Toledo International has lower revenue, but higher earnings than Illumina. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.39B	6.57	$850M	$5.50	34.70
Mettler-Toledo International	$4.09B	6.35	$869.19M	$42.64	30.16

89.4% of Illumina shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 2.9% of Illumina shares are held by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Illumina and Mettler-Toledo International tied by winning 8 of the 16 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ILMN vs. The Competition

Export

Metric	Illumina	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$28.88B	$3.64B	$6.77B	$12.60B
Dividend Yield	N/A	2.18%	2.67%	9.67%
P/E Ratio	34.70	21.35	26.91	23.97
Price / Sales	6.57	174.30	507.72	91.38
Price / Cash	27.50	150.24	49.71	59.37
Price / Book	10.71	8.00	10.56	6.16
Net Income	$850M	$23.81M	$3.60B	$331.71M
7 Day Performance	1.99%	-3.23%	-2.15%	-1.94%
1 Month Performance	18.27%	-0.70%	0.11%	-2.49%
1 Year Performance	87.07%	41.99%	22.63%	17.28%

Illumina Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ILMN Illumina	3.3036 of 5 stars	$190.87 -0.9%	$156.88 -17.8%	+103.1%	$28.88B	$4.39B	34.70	8,650	Positive News
QGEN Qiagen	4.2726 of 5 stars	$41.63 +0.5%	$43.34 +4.1%	-19.9%	$8.54B	$2.09B	21.74	5,654
TMO Thermo Fisher Scientific	4.5039 of 5 stars	$534.99 +1.2%	$602.14 +12.6%	+29.0%	$196.41B	$44.56B	29.41	125,000	Positive News Upcoming Earnings
A Agilent Technologies	4.8838 of 5 stars	$135.54 +1.1%	$159.35 +17.6%	+18.7%	$37.86B	$6.95B	27.22	18,100	Positive News
WAT Waters	3.5401 of 5 stars	$376.82 +1.0%	$401.60 +6.6%	+30.7%	$36.64B	$3.17B	47.88	7,900	Positive News Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ILMN) was last updated on 7/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Illumina (ILMN) Competitors

ILMN vs. QGEN, TMO, A, WAT, and MTD

How does Illumina compare to Qiagen?

Summary

How does Illumina compare to Thermo Fisher Scientific?

Summary

How does Illumina compare to Agilent Technologies?

Summary

How does Illumina compare to Waters?

Summary

How does Illumina compare to Mettler-Toledo International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN vs. The Competition

Illumina Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Illumina (ILMN) Competitors

ILMN vs. QGEN, TMO, A, WAT, and MTD

How does Illumina compare to Qiagen?

Which has preferable valuation & earnings, QGEN or ILMN?

Do analysts rate QGEN or ILMN?

Is QGEN or ILMN more profitable?

Do institutionals & insiders have more ownership in QGEN or ILMN?

Does the media prefer QGEN or ILMN?

Which has more risk & volatility, QGEN or ILMN?

Summary

How does Illumina compare to Thermo Fisher Scientific?

Do institutionals & insiders hold more shares of TMO or ILMN?

Is TMO or ILMN more profitable?

Does the media favor TMO or ILMN?

Which has higher earnings and valuation, TMO or ILMN?

Which has more risk & volatility, TMO or ILMN?

Do analysts rate TMO or ILMN?

Summary

How does Illumina compare to Agilent Technologies?

Which has preferable valuation and earnings, A or ILMN?

Is A or ILMN more profitable?

Does the media favor A or ILMN?

Do analysts rate A or ILMN?

Which has more volatility & risk, A or ILMN?

Do institutionals and insiders believe in A or ILMN?

Summary

How does Illumina compare to Waters?

Is ILMN or WAT more profitable?

Does the media refer more to ILMN or WAT?

Do insiders and institutionals believe in ILMN or WAT?

Which has more risk & volatility, ILMN or WAT?

Do analysts prefer ILMN or WAT?

Which has better earnings and valuation, ILMN or WAT?

Summary

How does Illumina compare to Mettler-Toledo International?

Is ILMN or MTD more profitable?

Does the media refer more to ILMN or MTD?

Do analysts prefer ILMN or MTD?

Which has more risk and volatility, ILMN or MTD?

Which has higher valuation and earnings, ILMN or MTD?

Do institutionals & insiders believe in ILMN or MTD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN vs. The Competition

Illumina Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools